Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 613-616, Vol. 69, No. 1
Departamento de Genética, Centro
Nacional de Investigaciones
Científicas,1 and Laboratorio de
Farmacología, Centro de Química
Farmacéutica,2 La Habana, Cuba
Received 18 April 2000/Returned for modification 16 June
2000/Accepted 25 October 2000
In this study, we analyzed whether attachment of Vibrio
cholerae vaccine strains to human intestinal epithelial cells can induce an interleukin-8 (IL-8) response. The IL-8 transcripts were
detected by PCR amplification of reverse-transcribed mRNA, and the gene
product secretion was measured by an enzyme-linked immunosorbent assay.
Infection of monolayers of the undifferentiated HT29-18N2 cell line
with reactogenic (JBK70 and 81) and nonreactogenic (CVD103HgR and 638)
vaccine strains of V. cholerae resulted in markedly higher
IL-8 expression by epithelial cells exposed to reactogenic strains than
by cells exposed to the nonreactogenic strains. Additionally,
epithelial cells produced IL-8 transcripts following stimulation with
cholera vaccine strains in a concentration-dependent manner. These
results represent a new insight into the inflammatory component of
reactogenicity and could be used as a predictive marker of vaccine
reactogenicity prior to human testing.
Cholera is traditionally considered
to be a noninflammatory diarrheal disease caused by Vibrio
cholerae serogroups O1 and O139 (10). Several groups
of investigators have constructed a wide range of live attenuated
V. cholerae O1 and O139 strains by deleting the CTX Strains, cell cultures, and infection protocol.
The V. cholerae strains used in this work are summarized in Table
1 and were grown as semiconfluent streaks
on Luria-Bertani agar. The HT29-18N2 cell line was provided by Tom E. Phillips (Department of Molecular Microbiology and Immunology,
University of Missouri, Columbia) and was maintained in a high-glucose
Dulbecco's modified medium supplemented with 10% fetal calf serum,
penicillin-streptomycin (10 U and 10 µg per ml), and amphotericin B
(0.5 µg/ml), hereafter referred to as complete medium. The cells were
incubated at 37°C in complete medium in an atmosphere of 5%
CO2. For all experiments, undifferentiated HT29-18N2 cells
were used to avoid mucus interference with adherence for all strains
assayed. Attachment of V. cholerae vaccine strains to the
intestinal epithelial cell line was essentially determined as described
previously (3). For IL-8 mRNA and gene product detection,
HT29-18N2 cells were seeded at 2 × 104 to 3 × 104 cells/cm2 onto 25-mm-diameter coverglasses
in six-well tissue culture plates in complete medium and incubated at
37°C in 5% CO2 until confluent. Twenty-four hours before
stimulation, the cell cultures were washed and maintained in fresh
complete medium without fetal calf serum. Duplicate coverglasses were
exposed to 106 to 107 CFU of each cholera
vaccine strain for 30 min, washed three times, transferred to fresh
Dulbecco's medium, and incubated for up to 8 h. In
dose-dependency experiments, the V. cholerae inoculum size
ranged from 104 to 107 CFU/well and RNA
extractions were performed 4 h postinfection.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.613-616.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Differential Interleukin-8 Response of Intestinal
Epithelial Cell Line to Reactogenic and Nonreactogenic Candidate
Vaccine Strains of Vibrio cholerae
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
genes
in order to immunize against cholera (2, 5, 9, 11, 16,
19). However, many of these strains have shown residual adverse
properties (reactogenicity) in volunteer studies (1, 12, 22,
23). The cellular basis of reactogenicity is not clear, but
there is some evidence of an intestinal inflammatory response. It was
postulated that close proximity or contact of bacterial cells to the
apical surface of the intestinal epithelium causes reactogenicity, due
to the induction of a local inflammatory response; this theory was
based on the lower reactogenicity observed for nonmotile mutants of
V. cholerae compared with parental motile vaccine strains in
volunteer studies (15). Furthermore, oral vaccination with
CVD110, a reactogenic strain, produced copious amounts of lactoferrin
and increased interleukin-8 (IL-8) levels in the stool of volunteers,
while a nonreactogenic strain (CVD103HgR) did not (21).
The proinflammatory cytokine IL-8 is a potent chemoattractant for
polymorphonuclear leukocytes and T lymphocytes (17).
Polymorphonuclear leukocytes, which are found in large numbers in
inflammatory diarrheas (6, 20), can induce chloride secretion similar to that seen in toxigenic secretory diarrhea illnesses (14) and could play an important role in the
diarrhea seen with live attenuated cholera vaccine strains. On the
other hand, epithelial cells infected with several invasive and some noninvasive enteric pathogens produced an IL-8 response
(8). However, the induction of proinflammatory signals by
the attachment of V. cholerae strains to intestinal
epithelial cell lines has not been investigated. Here, we examined the
impact of attachment of reactogenic and nonreactogenic live cholera
vaccine strains to human intestinal epithelial cells on the IL-8
response by using the undifferentiated HT29-18N2 cell line
(7), a clone derived from the HT29 human adenocarcinoma
cell line. This clone, when maintained in high-glucose Dulbecco's
modified medium supplemented with fetal serum, does not produce mucus
and mainly remains in the form of columnar enterocytes
(18).
TABLE 1.
Adherence of different V. cholerae vaccine
strains to the undifferentiated HT29-18N2 colonic epithelial cell line
RNA extraction, RT-PCR analysis, and cytokine assay.
Total
cellular RNA was extracted 0.5, 2, 4, and 8 h after challenge of
the epithelial cells with the different V. cholerae vaccine
strains by using the acid guanidinium thiocyanate-phenol-chloroform method (4). First-strand cDNA synthesis was performed by
using 1.5 µg of each purified RNA primed with 2 pmol of oligo(dT)
primer in a 20-µl reaction volume. Reverse transcriptions (RTs) were made by using the Reverse Transcription system (Promega, Madison, Wis.). Qualitative PCR analysis was performed with 1 µl of each cDNA
in a 50-µl reaction volume containing 0.2 mM deoxynucleoside triphosphate, 2 mM Mg2+, 0.5 µM concentrations of each
sense and antisense primer, and 1.25 U of Taq DNA
polymerase. All reagents for PCR amplification were purchased from
Boehringer (Mannheim, Germany). The PCR profile included a 94°C
denaturalization for 5 min, followed by 30 cycles of denaturalization
at 94°C for 1 min, annealing at 60°C for 1 min, extension at 72°C
for 2 min, and a final extension at 72°C for 10 min. The primers used
and the molecular sizes of the corresponding products were as follows:
-actin sense (5' GTG GGG CGC CCC AGG CAC CA 3') and antisense (5'
CTC CTT AAT GTC ACG CAC GAT TTC 3') (548 bp); IL-8 sense (5' ATG ACT
TCC AAG CTG GCC GTG 3') and antisense (5' TTA TGA ATT CTC AGC CCT CTT
CAA AAA CTT CTC 3') (302 bp). The IL-8 concentration was determined at
0.5, 2, 4, and 8 h postinfection in culture supernatants of
undifferentiated HT29-18N2 cells stimulated with reactogenic and
nonreactogenic cholera vaccine strains by the Quantikine enzyme-linked
immunosorbent assay (R & D Systems, Minneapolis, Minn.), with a
detection limit of less than 10 pg/ml. Both the RT-PCR analysis and
cytokine assay used unstimulated epithelial cell cultures as controls.
Tumor necrosis factor alpha (TNF-
)-treated epithelial cells were
used as positive controls for IL-8 stimulation.
-treated cells a strong IL-8 mRNA
expression was seen in 4 h (data not shown). Amplification of the
same cDNAs with primers for
-actin demonstrated that the expression
of the transcripts for this constitutive protein was unaffected in all
samples tested. The IL-8 mRNA induction by strain JBK70 became evident
at 2 h and increased for up to 8 h (Fig.
1); similar results were observed for
strain 81, except that IL-8 mRNA was evident 1.5 h earlier (Fig.
1). On the other hand, the nonreactogenic strains CVD103HgR and 638 also induced IL-8 mRNA within 2 h which also increased for up to
8 h (Fig. 1). Strikingly, IL-8 mRNA expression in the
nonreactogenic strains was, at all sampling times, markedly lower than
that induced by strain JBK70 or 81. Increases in IL-8 mRNA were
dependent on inoculum size, as demonstrated in dose-dependency
experiments for both reactogenic and nonreactogenic strains, with lower
levels of transcript expression in the latter (Fig.
2). Supernatants were collected from
V. cholerae-infected confluent monolayers and IL-8 secretion was measured by enzyme-linked immunosorbent assay. Unstimulated cells
did not produce detectable levels of IL-8 (i.e., levels were below 10 pg/ml), while TNF-
induced potent secretion of the IL-8 gene product
within 4 h (Table 2). Both
reactogenic strains (JBK70 and 81) induced secretion of IL-8, starting
at 4 h (Table 2). In contrast, no IL-8 was detected when
epithelial cells were exposed to 638, while the IL-8 gene product was
only detectable for CVD103HgR at 8 h (Table 2).
|
|
|
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Tom E. Philips and Richard A. Finkelstein for the HT29-18N2 cell line and to Arlenis M. Guerra for excellent technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Departamento de Genética, CNIC, Ave. 25 y 158, Cubanacan, Playa, P.O. Box 6412, La Habana, Cuba. Phone: (537) 21 80 66. Fax: (537) 28 04 97. E-mail: boris{at}biocnic.cneuro.edu.cu.
Editor: J. D. Clements
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Benitez, J. A.,
L. Garcia,
A. Silva,
H. Garcia,
R. Fando,
B. Cedre,
A. Perez,
J. Campos,
B. L. Rodriguez,
J. L. Perez,
T. Valmaseda,
O. Perez,
A. Perez,
M. Ramirez,
T. Ledon,
M. D. Yidy,
M. Lastre,
L. Bravo, and G. Sierra.
1999.
Preliminary assessment of safety and immunogenicity of a new CTX -negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.
Infect. Immun.
67:539-545 |
| 2. | Benitez, J. A., A. Silva, B. L. Rodriguez, R. Fando, J. Campos, A. Robert, H. Garcia, L. Garcia, J. L. Perez, R. Oliva, C. A. Torres, and T. Ledon. 1996. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains. Arch. Med. Res. 27:275-283[Medline]. |
| 3. | Benitez, J. A., R. G. Spelbrink, A. Silva, T. E. Phillips, C. M. Stanley, M. Boesman-Finkelstein, and R. A. Finkelstein. 1997. Adherence of V. cholerae to cultured differentiated human intestinal epithelial cells: an in vitro colonization model. Infect. Immun. 65:3474-3477[Abstract]. |
| 4. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 5. | Coster, T. S., K. P. Killeen, M. K. Waldor, D. T. Beattle, D. R. Spriggs, J. R. Kenner, A. Trofa, J. C. Sadoff, J. J. Mekalanos, and D. N. Taylor. 1995. Safety, immunogenicity and efficacy of live attenuated Vibrio cholerae O139 vaccine prototypes. Lancet 345:949-952[CrossRef][Medline]. |
| 6. |
Guerrant, R. L.,
V. Araujo,
E. Suares,
K. Kotloff,
A. A. M. Lima,
W. H. Cooper, and A. G. Lee.
1992.
Measurement of fecal lactoferrin as a marker of fecal leukocytes.
J. Clin. Microbiol.
30:1238-1242 |
| 7. |
Huet, C.,
L. Sahuquillo-Merino,
E. Condrier, and S. Louvard.
1987.
Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT29) provide new models for cell polarity and terminal differentiation.
J. Cell Biol.
105:345-358 |
| 8. | Kagnoff, M. F., and L. Eckmann. 1997. Perspectives series: host/pathogen interactions. J. Clin. Investig. 100:6-10[Medline]. |
| 9. | Kaper, J. B., H. Lockman, M. M. Baldini, and M. M. Levine. 1984. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 308:655-658[CrossRef][Medline]. |
| 10. | Kaper, J. B., J. G. Morris, Jr., and M. M. Levine. 1995. Cholera. Clin. Microbiol. Rev. 8:48-86[Abstract]. |
| 11. | Ketley, J. M., J. Michalski, J. E. Galen, M. M. Levine, and J. B. Kaper. 1993. Construction of genetically marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 111:15-22[CrossRef][Medline]. |
| 12. |
Levine, M. M.,
J. B. Kaper,
D. Herrington,
G. Losonsky,
J. G. Morris,
M. I. Clements,
R. E. Black,
B. Tall, and R. Hall.
1988.
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
Infect. Immun.
56:161-167 |
| 13. | Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-HgR. Lancet ii:467-470. |
| 14. | Madara, J. L., T. W. Patapoff, B. Gillece-Castro, S. P. Colgan, C. A. Parkos, C. Delp, and R. J. Mrsny. 1993. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J. Clin. Investig. 91:2320-2325. |
| 15. | Mekalanos, J. J., M. K. Waldor, C. L. Gardel, T. S. Coster, J. Kenner, K. P. Killeen, D. T. Beattie, A. Trofa, D. N. Taylor, and J. C. Sadoff. 1995. Live cholera vaccines: perspectives on their construction and safety. Bull. Inst. Pasteur 93:255-262[CrossRef]. |
| 16. |
Michalski, J.,
J. E. Galen,
A. Fasano, and J. B. Kaper.
1993.
Vibrio cholerae CVD110: a live attenuated El Tor vaccine strain.
Infect. Immun.
61:4462-4468 |
| 17. | Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of a novel proinflammatory supergene intercrine cytokine family. Annu. Rev. Immunol. 9:617-648[Medline]. |
| 18. | Phillips, T. E., R. Ramos, and S. L. Duncan. 1995. Differentiation of the HT29-18N2 human adenocarcinoma cell line in a protein-free medium: effect of insulin and transferrin. In Vitro Cell. Dev. Biol. 31:421-423. |
| 19. | Robert, A., A. Silva, J. A. Benitez, B. L. Rodriguez, R. Fando, J. Campos, D. K. Sengupta, M. Boesman-Finkelstein, and R. A. Finkelstein. 1996. Tagging a Vibrio cholerae El Tor candidate vaccine strain by disruption of its hemagglutinin/protease gene using a novel reporter enzyme: Clostridium thermocelum endoglucanase A. Vaccine 14:1517-1522[CrossRef][Medline]. |
| 20. | Silletti, R. P., A. G. Lee, and E. Ailey. 1996. Role of stool screening test in diagnosis of inflammatory bacterial enteritis and in selection of specimens likely to yield invasive enteric pathogens. J. Clin. Microbiol. 34:1161-1165[Abstract]. |
| 21. | Silva, T. N. J., M. A. Schleupner, C. O. Tacket, T. S. Steiner, J. B. Kaper, R. Edelman, and R. Guerrant. 1996. New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and O139 Vibrio cholerae. Infect. Immun. 64:2362-2364[Abstract]. |
| 22. |
Tacket, C. O.,
G. Losonski, and J. P. Nataro.
1993.
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a ctxA zot ace derivative of El Tor Ogawa Vibrio cholerae.
J. Infect. Dis.
168:1536-1540[Medline].
|
| 23. | Taylor, D. N., K. P. Killeen, D. C. Hack, J. R. Kenner, T. S. Coster, D. T. Beattie, J. Ezzell, T. Hyman, A. Trofa, M. J. Sjognen, A. Friedlander, J. J. Mekalanos, and J. C. Sadoff. 1994. Development of live, oral, attenuated vaccine against El Tor cholera. J. Infect. Dis. 170:1518-1523[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|